Skip to content

A randomized controlled clinical trial to assess the effectiveness and feasibility of the eye health intelligent agent in a community environment

Visual health grading and classification management mechanism and verification of eye health intelligent agent

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600129629
Enrollment
Unknown
Registered
2026-08-07
Start date
2026-08-17
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eye Diseases

Interventions

Agent Version 1 Application Group:After completing the baseline check and visual health assessment, the community doctor operated version 1 "Eye Health Agent" on the computer and conducted a multi-rou
Agent Version 2 Application Group:After completing the baseline check and visual health assessment, the community doctor operated version 2 "Eye Health Agent" on the computer and conducted a multi-rou
Agent Version 3 Application Group:After completing the baseline check and visual health assessment, the community doctor operated version 1 "Eye Health Agent" on the computer and conducted a multi-rou

Sponsors

Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age between 50 and 70; 2. Permanent residents who have resided in this community for more than 6 months and plan to continue residing in this community within the next 6 months; 3. Previously diagnosed with diabetes by a secondary or higher-level medical institution; 4. Previously diagnosed with hypertension by a secondary or higher-level medical institution.

Exclusion criteria

Exclusion criteria: 1. Individuals with severe cognitive impairments, mental illnesses, or extremely impaired hearing/visual abilities, who are unable to cooperate in completing the questionnaire survey and interacting with the intelligent agent; 2. Those with severe acute ocular infections, or who are unable to undergo fundus photography and OCT examinations due to severe opacity of the refractive media (such as extremely severe cataracts); 3. Those who have undergone ocular surgery within the past 3 months; 4. Those who refuse to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
Diagnostic consistency rate;Missed diagnosis rate;Rate of excessive medical visits;Accuracy rate of disease screening;

Secondary

MeasureTime frame
The acceptance and usage experience of agents by community patients;Community doctors' acceptance and usage experience of the agent; Implementation rate of medical visits;Changes in eye health status;

Countries

China

Contacts

Public ContactLi Wenwen

Fudan University

liwwen@fudan.edu.cn+86 1871776462

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026